| 000 | 01398 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250512001243.0 | ||
| 264 | 0 | _c19860819 | |
| 008 | 198608s 0 0 eng d | ||
| 022 | _a0022-1767 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGorczynski, R M | |
| 245 | 0 | 0 |
_aDo sugar residues contribute to the antigenic determinants responsible for protection and/or abolition of protection in Leishmania-infected BALB/c mice? _h[electronic resource] |
| 260 |
_bJournal of immunology (Baltimore, Md. : 1950) _cAug 1986 |
||
| 300 |
_a1010-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAlkaloids _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntigens, Protozoan _xanalysis |
| 650 | 0 | 4 |
_aCarbohydrates _xphysiology |
| 650 | 0 | 4 |
_aEpitopes _xanalysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycopeptides _xphysiology |
| 650 | 0 | 4 | _aImmune Tolerance |
| 650 | 0 | 4 | _aImmunization |
| 650 | 0 | 4 |
_aLeishmania _ximmunology |
| 650 | 0 | 4 |
_aLeishmania braziliensis _xgrowth & development |
| 650 | 0 | 4 |
_aLeishmaniasis, Mucocutaneous _ximmunology |
| 650 | 0 | 4 |
_aLeucine _xmetabolism |
| 650 | 0 | 4 |
_aMannose _xmetabolism |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aSwainsonine |
| 650 | 0 | 4 |
_aTunicamycin _xpharmacology |
| 773 | 0 |
_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 137 _gno. 3 _gp. 1010-6 |
|
| 999 |
_c2431034 _d2431034 |
||